Homepage

Media Release

Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in ...
Read More

COVID-19 Information Center

The information center provides a central hub for news, guidance and resources.
Read More
our-mission-and-purpose

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine
Read More

Explore Novartis

About Us
Who We Are
Our Work
What We Do
About Us
Corporate Responsibility
Careers
Job Search

Recent Updates

Strengthening the future of antibiotics manufacturing in Europe
Featured / Jul 28

Strengthening the future of antibiotics manufacturing in Europe

Richard Saynor via LinkedIn

Learn More
View All
Featured News / Jul 28

Strengthening the future of antibiotics manufacturing in Europe

Richard Saynor via LinkedIn
Read More
Media Release / Jul 27

Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

Read More
Media Release / Jul 21

Novartis delivered strong H1 performance. FY 2020 guidance confirmed at higher end for core operating income and lower end for sales.

Read More
Media Release / Jul 13

Sandoz launches generic antibiotic Daptomycin in US, strategically growing injectables portfolio and strengthening hospital offering

Read More
View All
All biologics including #biosimilars are slightly different as they are made from living cells. These differences a… https://t.co/El9GpP5yGB 1 day 8 hours ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More